Download video

01 Medicine of the week: 5 HT3 – receptor antagonists

6 views

Lékařská fakulta Masarykovy univerzity

1 day ago

01 Medicine of the week: 5 HT3 – receptor antagonists

01 Medicine of the week: 5 HT3 – receptor antagonists

INLURIYO (imlunestrant) - Breast Cancer! #saroarakelians #pharmacytalkusa #breastcancer #cancer
3:04
INLURIYO (imlunestrant) - Breast Cancer! #saroarakelians #pharmacytalkusa #breastcancer #cancer
by Pharmacy Talk USA
GLP-1 and SGLT-2: Treatments Too Good to Ignore?
5:04
GLP-1 and SGLT-2: Treatments Too Good to Ignore?
by RheumNow
Risk Identification Part 2
1:47:00
Risk Identification Part 2
by PharmaIdiots
12 October BE 2568
3:01
12 October BE 2568
by Drugs it easy! Preclinical Pharma fun
Nurtec, Ubrelvy, and Reyvow-New Drugs for Acute Migraine Treatment. Part 2B. Pharmacy medications.
19:41
Nurtec, Ubrelvy, and Reyvow-New Drugs for Acute Migraine Treatment. Part 2B. Pharmacy medications.
by The PharmEZ Tutor
Multiple Sclerosis medications #saroarakelians #pharmacytalkusa #multiplesclerosis #drugs
3:07
Multiple Sclerosis medications #saroarakelians #pharmacytalkusa #multiplesclerosis #drugs
by Pharmacy Talk USA
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
58:39
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
by Fit Rx Health + Wellness
Exciting New Advances in Biotech! | Introduction to IL-2 Immunotherapy | Medicenna Miniseries Ep. 1
2:46
Exciting New Advances in Biotech! | Introduction to IL-2 Immunotherapy | Medicenna Miniseries Ep. 1
by Medicenna Therapeutics
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
1:10
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
by VJOncology
Pharmacology of pertuzumab (Perjeta) ; Mechanism of action, Pharmacokinetics, Uses, Effects
2:05
Pharmacology of pertuzumab (Perjeta) ; Mechanism of action, Pharmacokinetics, Uses, Effects
by MBBS NAIJA
AUGMENT-101 trial: revumenib in patients with R\/R KMT2Ar acute leukemia
4:06
AUGMENT-101 trial: revumenib in patients with R\/R KMT2Ar acute leukemia
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dupilumab improves health-related quality of life: Results from the phase 3 SINUS studies
1:32
Dupilumab improves health-related quality of life: Results from the phase 3 SINUS studies
by Allergy
Q1 Q2 Q3 De-formulation \& Equivalence
5:55
Q1 Q2 Q3 De-formulation \& Equivalence
by Pharma Learning In Depth
Multiplexed optogenetic control, using PA- Vav2 and PI-Rac1 in the same cell.
0:13
Multiplexed optogenetic control, using PA- Vav2 and PI-Rac1 in the same cell.
by UNC Pharmacology
Q2
7:01
Q2
by HoungJunHongBiology
🩸 Bacteremia and Clinical Resistance Objective 2 | Spectrum Glycopeptide, Lipopeptides \& β-Lactams 🔬
25:43
🩸 Bacteremia and Clinical Resistance Objective 2 | Spectrum Glycopeptide, Lipopeptides \& β-Lactams 🔬
by Alireza FakhriRavari, PharmD, BCPS, BCIDP, AAHIVP
ARE YOUR MEDICATIONS PUTTING YOU AT RISK?
3:58
ARE YOUR MEDICATIONS PUTTING YOU AT RISK?
by Call on the Chemist
RC48-C016: disitamab vedotin \& toripalimab vs chemotherapy in HER2+ la\/mUC
1:33
RC48-C016: disitamab vedotin \& toripalimab vs chemotherapy in HER2+ la\/mUC
by VJOncology
28 Nitrofurantoin Mechanism, Use, and Toxicity
6:21
28 Nitrofurantoin Mechanism, Use, and Toxicity
by Pharmacology
ANTI HISTAMINES\/ PHARMACOLOGY\/ TYPES OF ANTIHISTAMINES\/ CLASSIFICATION
29:42
ANTI HISTAMINES\/ PHARMACOLOGY\/ TYPES OF ANTIHISTAMINES\/ CLASSIFICATION
by Dewdear Academy
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP
1:24
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP
by Allergy
AI Scribes Found their Favorite Doctors
3:57
AI Scribes Found their Favorite Doctors
by RheumNow